0R15 8539.0 2.1534% 0R1E 8600.0 3.3654% 0M69 None None% 0R2V 190.25 -0.1312% 0QYR 1345.5 2.0871% 0QYP 424.0 0.5931% 0LCV 146.6464 -1.3147% 0RUK None None% 0RYA 1631.0 -0.6094% 0RIH 171.3 0.9131% 0RIH 174.9 2.1016% 0R1O 186.0 9820.0% 0R1O None None% 0QFP None None% 0M2Z 298.3 -0.6495% 0VSO None None% 0R1I None None% 0QZI 474.5 0.6363% 0QZ0 220.0 0.0% 0NZF None None%
Last update at 2024-05-16T15:36:00Z
Breakdown | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 |
Income before tax | 291.50M | 304.40M | 252.90M | 224.10M | 206.70M |
Minority interest | 0.20M | 0.20M | 0.60M | -0.70000M | -0.70000M |
Net income | 234.50M | 244.40M | 203.40M | 184.40M | 169.80M |
Selling general administrative | 404.40M | 316.70M | 267.90M | 270.10M | 242.40M |
Selling and marketing expenses | 210.10M | 168.00M | 144.60M | 162.00M | 176.80M |
Gross profit | 922.90M | 763.60M | 653.30M | 665.50M | 637.00M |
Reconciled depreciation | 101.60M | 88.90M | 91.20M | 84.70M | 66.20M |
Ebit | 309.00M | 312.70M | 263.00M | 235.90M | 217.80M |
Ebitda | 410.60M | 401.60M | 354.20M | 320.60M | 282.30M |
Depreciation and amortization | 101.60M | 88.90M | 91.20M | 84.70M | 64.50M |
Non operating income net other | - | - | - | - | - |
Operating income | 308.40M | 278.90M | 240.80M | 233.40M | 217.80M |
Other operating expenses | 1544.40M | 1246.40M | 1077.40M | 1105.00M | 993.10M |
Interest expense | 17.50M | 8.30M | 10.10M | 11.80M | 9.40M |
Tax provision | 57.20M | 60.20M | 49.60M | 39.70M | 36.90M |
Interest income | 1.80M | 0.20M | 0.90M | 0.60M | 0.40M |
Net interest income | -16.50000M | -8.80000M | -9.90000M | -11.90000M | -9.90000M |
Extraordinary items | - | - | - | - | - |
Non recurring | - | - | - | - | - |
Other items | - | - | - | - | - |
Income tax expense | 57.20M | 60.20M | 49.60M | 39.70M | 36.90M |
Total revenue | 1852.80M | 1525.30M | 1318.20M | 1338.40M | 1210.90M |
Total operating expenses | 614.50M | 484.70M | 412.50M | 432.10M | 419.20M |
Cost of revenue | 929.90M | 761.70M | 664.90M | 672.90M | 573.90M |
Total other income expense net | -39.10000M | 22.70M | 6.80M | -16.00000M | -11.10000M |
Discontinued operations | - | - | - | - | - |
Net income from continuing ops | 234.30M | 244.20M | 203.30M | 184.40M | 169.80M |
Net income applicable to common shares | 234.50M | 244.40M | 203.40M | 184.40M | 169.80M |
Preferred stock and other adjustments | - | - | - | - | - |
Breakdown | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 |
Total assets | 2788.40M | 2197.00M | 1877.90M | 1937.80M | 1583.80M |
Intangible assets | 472.30M | 325.20M | 290.00M | 328.40M | 245.20M |
Earning assets | - | - | - | - | - |
Other current assets | 326.50M | 326.50M | 272.20M | 298.30M | 260.70M |
Total liab | 1189.50M | 793.90M | 710.30M | 800.90M | 602.40M |
Total stockholder equity | 1598.80M | 1402.70M | 1167.00M | 1137.60M | 981.40M |
Deferred long term liab | - | 41.70M | 38.90M | 36.10M | 33.10M |
Other current liab | 224.30M | 261.40M | 163.20M | 1.30M | 121.80M |
Common stock | 38.00M | 38.00M | 38.00M | 38.00M | 38.00M |
Capital stock | 38.00M | 38.00M | 38.00M | 38.00M | 38.00M |
Retained earnings | 1415.80M | 1274.80M | 1065.80M | 949.20M | 810.10M |
Other liab | 102.30M | 85.80M | 88.30M | 94.20M | 94.90M |
Good will | 1120.50M | 908.70M | 808.50M | 838.40M | 694.00M |
Other assets | 56.10M | 48.20M | 54.10M | 42.80M | 34.50M |
Cash | 169.50M | 157.40M | 134.10M | 106.30M | 81.20M |
Cash and equivalents | - | - | - | - | - |
Total current liabilities | 341.20M | 363.90M | 248.00M | 313.20M | 213.10M |
Current deferred revenue | -184.00000M | -228.20000M | -118.20000M | 37.10M | - |
Net debt | 596.70M | 274.80M | 256.20M | 375.30M | 181.70M |
Short term debt | 20.20M | 88.00M | 16.30M | 88.10M | 9.20M |
Short long term debt | 1.00M | 72.50M | 3.00M | 75.10M | 9.20M |
Short long term debt total | 766.20M | 432.20M | 390.30M | 481.60M | 262.90M |
Other stockholder equity | -1453.80000M | 89.90M | -1103.80000M | -987.20000M | 133.30M |
Property plant equipment | 222.90M | 194.00M | 180.80M | 184.30M | 112.40M |
Total current assets | 895.60M | 712.70M | 574.10M | 575.20M | 486.20M |
Long term investments | - | - | - | - | 3.90M |
Net tangible assets | 6.00M | 168.80M | 107.40M | 6.90M | 75.30M |
Short term investments | - | 0.00000M | - | - | - |
Net receivables | 410.70M | 325.80M | 253.10M | 279.00M | 241.20M |
Long term debt | 677.30M | 287.60M | 322.30M | 345.00M | 253.70M |
Inventory | 312.40M | 228.80M | 167.80M | 170.60M | 144.30M |
Accounts payable | 280.70M | 242.70M | 186.70M | 186.70M | 82.10M |
Total permanent equity | - | - | - | - | - |
Noncontrolling interest in consolidated entity | - | - | - | - | - |
Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
Accumulated other comprehensive income | - | - | - | -224.10000M | -152.20000M |
Additional paid in capital | - | - | - | - | - |
Common stock total equity | - | - | 38.00M | 38.00M | 38.00M |
Preferred stock total equity | - | - | - | - | - |
Retained earnings total equity | - | - | - | - | - |
Treasury stock | - | - | -20.90000M | -14.30000M | -4.70000M |
Accumulated amortization | - | - | - | - | - |
Non currrent assets other | 53.10M | 45.80M | 13.90M | 5.40M | 3.90M |
Deferred long term asset charges | - | - | - | - | - |
Non current assets total | 1892.80M | 1484.30M | 1303.80M | 1362.60M | 1097.60M |
Capital lease obligations | 87.90M | 72.10M | 65.00M | 61.50M | - |
Long term debt total | - | - | - | - | - |
Breakdown | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 |
Investments | -368.90000M | -0.70000M | -3.40000M | -4.80000M | -4.80000M |
Change to liabilities | 15.10M | 36.10M | 7.90M | 8.90M | 8.20M |
Total cashflows from investing activities | -368.90000M | -134.70000M | -64.20000M | -276.40000M | -104.00000M |
Net borrowings | 238.20M | 14.30M | -93.60000M | 142.70M | -43.90000M |
Total cash from financing activities | 121.00M | -81.90000M | -183.50000M | 53.70M | -113.60000M |
Change to operating activities | -50.40000M | -12.00000M | 0.70M | -2.50000M | -3.50000M |
Net income | 308.40M | 278.90M | 240.80M | 233.40M | 169.80M |
Change in cash | 11.80M | 25.60M | 25.70M | 33.30M | 2.40M |
Begin period cash flow | 156.70M | 131.10M | 105.40M | 72.10M | 69.70M |
End period cash flow | 168.50M | 156.70M | 131.10M | 105.40M | 72.10M |
Total cash from operating activities | 258.00M | 237.40M | 277.60M | 255.50M | 219.00M |
Issuance of capital stock | - | - | - | - | - |
Depreciation | 101.60M | 88.90M | 91.20M | 84.70M | 66.20M |
Other cashflows from investing activities | 0.70M | 0.20M | 0.80M | 0.50M | 0.40M |
Dividends paid | 73.30M | 68.70M | 63.70M | 61.20M | 57.20M |
Change to inventory | -54.90000M | -51.90000M | -6.70000M | -5.10000M | -9.20000M |
Change to account receivables | -52.40000M | -43.60000M | 4.30M | -9.00000M | -15.30000M |
Sale purchase of stock | -22.30000M | -19.30000M | -16.20000M | -16.70000M | -3.80000M |
Other cashflows from financing activities | 194.30M | -13.20000M | -119.80000M | 114.90M | 57.70M |
Change to netincome | 12.10M | -24.50000M | -22.30000M | -5.90000M | 2.80M |
Capital expenditures | 45.90M | 40.00M | 42.20M | 48.80M | 42.10M |
Change receivables | - | - | - | - | - |
Cash flows other operating | - | - | - | - | - |
Exchange rate changes | - | - | - | - | - |
Cash and cash equivalents changes | - | - | - | - | - |
Change in working capital | -90.20000M | -71.40000M | 6.20M | -7.70000M | -19.80000M |
Stock based compensation | 12.90M | 5.00M | 3.70M | 4.80M | 4.70M |
Other non cash items | -67.30000M | -86.10000M | -5.80000M | -2.50000M | -1.90000M |
Free cash flow | 212.10M | 197.40M | 235.40M | 206.70M | 176.90M |
Sector: Industrials Industry: Conglomerates
Company | Change (GBP) | Price (GBP) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
---|---|---|---|---|---|---|---|---|
HLMA Halma PLC |
-4.0 0.17% | 2352.00 | 36.35 | 26.67 | 4.58 | 5.27 | 4.83 | 22.06 |
JAR Jardine Matheson Holdings Limited |
- -% | 62.50 | 0.37 | 9.94 | 0.0048 | 0.62 | 0.67 | 6.84 |
CGEO Georgia Capital PLC |
-26.0 2.64% | 959.00 | 2.00 | - | 3.21 | 0.49 | 0.32 | -71.6148 |
MSI MS INTERNATIONAL plc |
- -% | 995.00 | 21.07 | - | 1.43 | 3.25 | 1.01 | 8.07 |
RFX Ramsdens Holdings PLC |
12.50 6.58% | 202.50 | 8.54 | 13.44 | 0.86 | 1.53 | 0.93 | 5.04 |
Halma plc, together its subsidiaries, provides technology solutions in the safety, health, and environmental markets in the United States, Mainland Europe, the United Kingdom, the Asia Pacific, Africa, the Middle East, and internationally. It operates through three segments: Safety, Environmental & Analysis, and Medical. The Safety segment provides fire safety, fire detection and fire suppression; safe movement in public, commercial, and industrial spaces; elevator safety; communications in emergencies; control of access in potentially hazardous industrial and commercial environments; electrical safety; and the safe management of pipelines and storage assets solutions. This segment serves shops and restaurants, healthcare facilities, and offices and stadiums; industrial and logistics assets; public spaces and critical infrastructure; and aerospace, and rail and automotive markets. The Environmental & Analysis segment offers optical, optoelectronic, and spectral imaging systems; environmental monitoring, water and waste water analysis and treatment, gas analysis and detection, and optical analysis systems. It serves the optical analysis, water analysis and treatment, gas detection, and environmental monitoring markets. The Medical segment provides critical fluidic components used by medical diagnostics and original equipment manufacturers; components, devices and systems that provide information and analytics to understand patient health and enable providers to make decisions across the continuum of care; technologies and solutions to enable in-vitro diagnostic systems and life-science discoveries and development; and technologies that enable treatment across clinical specialties. This segment serves the life sciences, health assessment and analytics, and therapeutic solutions market. The company was incorporated in 1894 and is headquartered in Amersham, the United Kingdom.
Misbourne Court, Amersham, United Kingdom, HP7 0DE
Name | Title | Year Born |
---|---|---|
Mr. Andrew John Williams | Group CEO, Member of Exec. Board & Exec. Director | 1967 |
Mr. Marc A. Ronchetti | Group CFO, Member of Exec. Board & Exec. Director | NA |
Ms. Jennifer Ward | Group Talent, Culture & Communications Director, Member of Exec. Board and Exec. Director | NA |
Ms. Inken Braunschmidt | Chief Innovation & Digital Officer and Member of Exec. Board | NA |
Ms. Catherine E. Michel | CTO & Member of Exec. Board | 1973 |
Ms. Funmi Adegoke | Group Gen. Counsel, Chief Sustainability Officer & Member of Exec. Board | NA |
Ms. Constance F. Baroudel | Sector Chief Exec. of Environmental & Analysis and Member of Exec. Board | 1974 |
Ms. Wendy McMillan | Sector Chief Exec. of Safety & Member of Exec. Board | NA |
Mr. Steve Brown | Sector Chief Exec. of Healthcare & Member of Exec. Board | NA |
Mr. Aldous Wong | Pres of Halma Asia Pacific, Adviser & Member of Exec. Board | NA |
Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).